DailyStocks Stock Article Search

https://www.fool.com/investing/2024/08/20/2-cheap-passive-income-stocks-to-buy-now/?source=iedfolrf0000001 Aug 20, 2024 - Passive income stocks offer potential for steady returns and financial security in retirement. 0

https://www.fool.com/investing/2024/08/17/3-dividend-stocks-to-double-up-on-right-now/?source=iedfolrf0000001 Aug 17, 2024 - How does a 5.7% dividend yield sound? 0

https://www.zacks.com/stock/news/2323142/pharma-stock-roundup-azn-gets-approvals-for-imfinzi-expanded-use-mrk-inks-new-deal?cid=CS-ZC-FT-analyst_blog|stock_roundup-2323142 Aug 16, 2024 - Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi. 0

https://www.zacks.com/stock/news/2322158/evotec-evo-rises-12-on-75m-milestone-payment-from-bmy?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322158 Aug 14, 2024 - A $75 million performance-based and program-based milestone payment has been triggered in favor of Evotec (EVO) under its strategic collaboration with Bristol Myers for molecular glue degraders. 0

https://www.zacks.com/stock/news/2321469/here-s-how-to-play-novo-nordisk-nvo-after-q2-earnings-miss?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321469 Aug 13, 2024 - Novo Nordisk (NVO) is an excellent stock to buy for long-term gains, driven by the stellar performance of its GLP-1 drugs. New investors should utilize the existing opportunity to make an entry. 0

https://www.zacks.com/stock/news/2321388/3-big-drug-stocks-to-watch-on-raised-2024-earnings-sales-view?cid=CS-ZC-FT-analyst_blog|investment_ideas-2321388 Aug 13, 2024 - Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024. 0

https://www.fool.com/investing/2024/08/12/prediction-buying-biotech-and-pharma-stocks-during/?source=iedfolrf0000001 Aug 12, 2024 - There isn't much to suggest these businesses are actually vulnerable. 0

https://www.fool.com/investing/2024/08/11/is-pfizer-stock-a-buy-now-after-earnings/?source=iedfolrf0000001 Aug 11, 2024 - This pharmaceutical blue chip could be ready to rally higher. 0

https://www.zacks.com/stock/news/2320137/buy-5-surging-old-economy-stocks-to-tap-market-rally?cid=CS-ZC-FT-analyst_blog|investment_ideas-2320137 Aug 09, 2024 - Five old economy stocks with strong near-term potential are: NEM, GE, PFE, PGR, BSX. 0

https://www.zacks.com/commentary/2316397/volatility-spikes-3-low-beta-stocks-to-buy?cid=CS-ZC-FT-investment_ideas-2316397 Aug 05, 2024 - During periods of heightened volatility, low-beta stocks can provide a valuable layer of defense and a more balanced risk profile. 0